Consider COVID Vaccination History When Assessing Adenopathy on Mammography
Axillary lymphadenopathy more likely within 14 days after vaccination; persistent axillary lymphadenopathy seen up to 43 weeks later
COVID19
Vaccination Cuts Severe COVID-19 Risk in Heart Transplant Patients
Among orthotopic heart transplant (OHT) recipients, COVID-19 vaccination is associated with fewer COVID-19 infections, hospitalizations, and deaths and no heart transplant-specific adverse events.
Higher Vaccination Coverage Linked to Lower COVID-19 Mortality
Higher vaccination coverage is associated with lower rates of COVID-19 mortality and incidence in the United States.
Risk for Myopericarditis Minimal Following COVID-19 Vaccination
A study was conducted to determine the incidence of myopericarditis following COVID-19 vaccination compared with non-COVID-19 vaccination.
White House Moves to Make COVID-19 Antiviral Pills More Widely Available
Plans to nearly double the number of pharmacies and other locations that carry the antiviral pill Paxlovid for COVID-19 were announced Tuesday by the Biden administration.
Early Effectiveness Assessed for Fourth Dose of BNT162b2 Vaccine
A fourth dose of the BNT162b2 vaccine is effective for reducing the risk for COVID-19-related outcomes in the short term.
AACR: Novel COVID-19 Vaccine Aimed at Immunocompromised Patients
Interim results of early research show that a new vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), CoVac-1, induces T-cell immune responses in 93% of patients with B-cell deficiencies.
ACC Issues Expert Guidance for Cardiovascular Sequelae After SARS-CoV-2 Infection
The American College of Cardiology has published guidelines for managing adult patients with cardiovascular sequelae after COVID-19 infection.
FDA Authorizes Shelf-Life Extension for Certain COVID-19 Vaccines
The FDA has extended shelf-life for the Janssen COVID-19 vaccine and the Pfizer-BioNTech COVID-19 vaccine following a thorough review of data submitted by both manufacturers.
Veklury Approval Expanded to Include COVID-19 Treatment in Younger Children
The approval was supported by data from a phase 2/3 CARAVAN study.
- Loading...
Loading...
Next post in Pediatric Cardiology
Loading... 
Loading...